Press Release: Rarecells, Inc. Appoints Dr. Neil Kurtz to Board of Directors
Press Release: Rarecells announces Appointment of New Director to the Board
Press release : Rarecells, Inc. announces successful Series A funding, reaching $13 Million raised to develop Liquid Biopsy Early Cancer Detection Tests
Press release : Rarecells, Inc. to fund a clinical study at Columbia University of its ISET® -AML test for early detection of Acute Myeloid Leukemia (AML)
Prof. Patrizia Paterlini-Brechot - Rarecells, Inc. - embarks on the search for the First Cell to beat cancer
Press release : ISET® technology makes Circulating Tumor Cells accessible to target PDAC mutant genes detection in pancreatic cancer with an accuracy demonstrated by a targeted scNGS
Press release : ISET® test results show substantial improvement in early detection of prostate cancer by identifying PSA-positive Circulating Tumor Cells
2nd Liquid Biopsies Congress - Global Exchange
Press release : ISET® technology applied to DLA products from NSCLC patients identified more CTC than other systems
We are hiring!
Menu
Rarecells, Inc. USA
Rarecells Diagnostics
Paris, France
- contact@rarecells.com
- +33 (0) 1 40 61 56 02